Fingerprint
Dive into the research topics of 'Elotuzumab therapy for relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Elotuzumab therapy for relapsed or refractory multiple myeloma
ELOQUENT-2 Investigators
Research output: Contribution to journal › Article › peer-review
1145
Citations
(Scopus)